DOI QR코드

DOI QR Code

Development of aortic endothelial cells to express CD37 and CD73 isolated from alpha 1,3-galactosyltransferase knock-out and MCP expressing pig

alpha 1,3-galactosyltransferase 기능 제거 및 MCP 발현 형질전환 돼지의 대동맥 혈관내피세포에 CD37/CD73 발현 세포주 개발

  • No, Jin-Gu (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Byun, Sung-June (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Yang, Hyeon (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Ock, Sun A (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Woo, Jae-Seok (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Lee, Hwi-Cheul (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Hwang, In-sul (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Kim, Ji-Youn (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Park, Sang Hyoun (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Lee, Joo Young (Animal Biotechnology Division, National Institute of Animal Science, RDA) ;
  • Oh, Keon Bong (Animal Biotechnology Division, National Institute of Animal Science, RDA)
  • 노진구 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 변승준 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 양현 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 옥선아 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 우제석 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 이휘철 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 황인설 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 김지윤 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 박상현 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 이주영 (농촌진흥청 국립축산과학원 동물바이오공학과) ;
  • 오건봉 (농촌진흥청 국립축산과학원 동물바이오공학과)
  • Received : 2018.08.23
  • Accepted : 2018.09.27
  • Published : 2018.09.30

Abstract

Acute vascular rejection has been known as a main barrier occurring in a xenograted tissue of alpha 1,3-galactosyltransferase knock-out (GalT KO) pig into a non-human primate (NHP). Adenosine which is a final metabolite following sequential hydrolysis of nucleotide by ecto-nucleotidases such as CD39 and CD73, act as a regulator of coagulation, and inflammation. Thus xenotransplantation of CD39 and CD73 expressing pig under the GalT KO background could lead to enhanced survival of recipient NHP. We constructed a human CD39 and CD73 expression cassette designed for endothelial cell-specific expression using porcine Icam2 promoter (pIcam2-hCD39/hCD73). We performed isolation of endothelial cells (pAEC) from aorta of 4 week-old GalT KO and membrane cofactor protein expressing pig ($GalT^{-MCP/-MCP}$). We were able to verify that isolated cells were endothelial-like cells using immunofluorescence staining analysis with von Willebrand factor antibody, which is well known as an endothelial maker, and tubal formation assay. To find optimal condition for efficient transfection into pAEC, we performed transfection with GFP expression vector using four programs of nucleofection, M-003, U-023, W-023 and Y-022. We were able find that the program W-023 was optimal for pAEC with regard to viability and transfection efficiency by flow cytometry and fluorescent microscopy analyses. Finally, we were able to obtain $GalT^{-MCP/-MCP}/CD39/CD73$ pAEC expressing CD39 and CD73 at levels of 33.3% and 26.8%, respectively. We suggested that pACE isolated from $GalT^{-MCP/-MCP}$ pig might be provided as a basic resource to understand biochemical and molecular mechanisms of the rejections and as an alternative donor cells to generate $GalT^{-MCP/-MCP}/CD39/CD73$ pig expressing CD39 and CD73 at endothelial cells.

Keywords

References

  1. Annette M, Iris H, Carmen S, Maya N, Klaus-Michael M and James C. 2002. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp. Mol. Path. 72:221-229. https://doi.org/10.1006/exmp.2002.2424
  2. Bastid J, cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF and Bensussan A. 2013. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 32:1743-1751. https://doi.org/10.1038/onc.2012.269
  3. Beavis PA, Stagg J, Darcy PK and Smyth MJ. 2012. CD73: a potent suppressor of antitumor immune responses. Trends Immunol. 33:231-237. https://doi.org/10.1016/j.it.2012.02.009
  4. Buhler L, Yamada K, Kitamura H, Alwayn IP, Basker M, Appel JZ 3rd, Colvin RB, White-Scharf ME, Sachs DH, Robson SC, Awwad M and Cooper DK. 2001. Pig kidney transplantation in baboos: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 72:1743-1752. https://doi.org/10.1097/00007890-200112150-00007
  5. Cooper DK, Ezzelarab MB, Hara H, Iwase H, Lee W, Wijkstrom M and Bottino R. 2016. The pathobiology of pig-to-primate xenotransplantation: a historical review. Xenotransplantation 23:83-105. https://doi.org/10.1111/xen.12219
  6. Cooper DK, Human PA, Lexer G, Rose AG, Rees J, Keraan M and Du Toit E. 1988. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J. Heart Transplant. 7:238-246.
  7. Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE, Cowell-Lucero JL, Wells KD, Colman A, Polejaeva IA and Ayares DL. 2002. Targeted disruption of the alpha-1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20:251-255. https://doi.org/10.1038/nbt0302-251
  8. Dalloul A. 2013. B-cell-mediated strategies to fight chronic allograft rejection. Front. Immunol. 4:444.
  9. Deaglio S and Robson SC. 2011. Ectonucleotidases as regulators of purinergic signaling in thrombosis, imflammation, and immunity. Adv. Pharmacol. 61:301-332.
  10. DeCicco-Skinner KL, Henry GH, Cataisson C, Tabib T, Gwilliam JC, Watson NJ, Bullwinkle EM, Falkenburg L, O'Neill RC, Morin A and Wiest JS. 2014. Endothelial cell tube formation assay for the in vitro study of angiogenesis. J. Vis. Exp. 1:e51312.
  11. Dwyer K, Robson S, Nandurkar H, Campbell D, Gock H, Murray-Segal L, Fisicaro N, Mysore T, Kaczmarek E, Cowan P and d'Apice A. 2004. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J. Clin. Invest. 113:1440-1446. https://doi.org/10.1172/JCI19560
  12. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC and Rosenberg RD. 1999. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5:1010-1017. https://doi.org/10.1038/12447
  13. Gollackner B, Goh SK and Qawi. 2004. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 77:1735-1741. https://doi.org/10.1097/01.TP.0000131167.21930.B8
  14. Grunewald JK and Ridley AJ. 2010. CD73 represses pro-inflammatory responses in human endothelial cells. J. inflamm. 7:10. https://doi.org/10.1186/1476-9255-7-10
  15. Hasegawa T, Bouis D, Liao H, Visovatti SH and Pinsky DJ. 2008. Ecto-5' nucleotidase (CD73)-mediate adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ. Res. 103:1410-1421. https://doi.org/10.1161/CIRCRESAHA.108.180059
  16. Hasko G, Linden J, Cronstein B and Pacher P. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug. Discov. 7:759-770. https://doi.org/10.1038/nrd2638
  17. Hewett PW and Murray JC. 1993. Human microvessel endothelial cells; isolation, culture and characterization. In vitro Cell Dev. Biol. 29A:823-830.
  18. Houser SL, Kuwaki K, Knosalla C, Dor FJ, Collackner B, Cheng J, Shimizu A, Schuurman HJ and Cooper DK. 2004. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 11:416-425. https://doi.org/10.1111/j.1399-3089.2004.00155.x
  19. Ierino FL, Kozlowski T, Siegel JB, Shimizu A, Colvin RB, Banerjee PT, Cooper DK, Cosimi AB, Bach FH, Sachs DH and Robson SC. 1998. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 66:1439-1450. https://doi.org/10.1097/00007890-199812150-00006
  20. Imai M, Takigami K, Guckelberger O, Kaczmarek E, Csizmadia E, Bach FH and Robson SC. 2000. Recominant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 70:864-870. https://doi.org/10.1097/00007890-200009270-00003
  21. Ingulli E. 2010. Mechanism of cellular rejection in transplantation. Pediatr. Nephrol. 25:61-74. https://doi.org/10.1007/s00467-008-1020-x
  22. Jang H, Kim DU, Kim EJ, Hwang SS, Oh KB and Lee JW. 2012. Identification of Endothelial Specific Region in the Intracellular Adhesion Molecule-2 (ICAM2) Promoter of Miniature Pig. Reprod. Develop. biol. 36:207-212.
  23. Jocelyne K, Alexander O, Claes W, Cabriele G, Walter R and Ulrich V. 2000. Vasopressin-induced von willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J. Clin. Invest. 106:107-116. https://doi.org/10.1172/JCI9516
  24. Kim T and Eberwine J. 2010. Mammalian cell transfection: the present and the future. Anal Bioanal. Chem. 397:3173-3178. https://doi.org/10.1007/s00216-010-3821-6
  25. Ko N, Lee JW, Hwang SS, Kim B, Ock SA, Lee SS, Im GS, Kang MJ, Park JK, Oh SJ and Oh KB. 2013. Nucleofection mediated alpha 1,3-galactosyltransferase gene inactivation and membrane cofactor protein expression for pig-to-primate xenotransplantation. Anim. Biotechnol. 24:253-267. https://doi.org/10.1080/10495398.2012.752741
  26. Kolber-Simonds D, Lai L, Watt SR, Denaro M, Arn S, Augenstein ML, Betthauser J, Carter DB, Greenstein JL, Hao Y, Im GS, Liu Z, Mell GD, Murphy CN, Park KW, Rieke A, Ryan DJ, Sachs DH, Forsberg EJ, Prather RS and Hawley RJ. 2004. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. Natl. Acad. Sci. USA. 101:7335-7340. https://doi.org/10.1073/pnas.0307819101
  27. Kopp CW, Siegel JB, Hancock WW, Anrather J, Winkler H, Ceczy CL, Kaczmarek E, Bach FH and Robson SC. 1997. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63:749-758. https://doi.org/10.1097/00007890-199703150-00023
  28. Koszalka P, Ozuyaman B, Huo Y, Zernecke A, Flogel U, Braun N, Buchheiser A, Decking UK, Smith ML, Sevigny J, Gear A, Weber AA, Molojavyi A, Ding Z, Weber C, Ley K, Zimmermann H, Codecke A and Schrader J. 2004. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95:814-821. https://doi.org/10.1161/01.RES.0000144796.82787.6f
  29. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ, Sachs DH and Cooper DK. 2005. Heart transplantation in baboons using alpha-1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11:29-31. https://doi.org/10.1038/nm1171
  30. Laurent L, Fabrice B and Jacques H. 2007. Endothelial cell migration during angiogenesis. Circ. Res. 100:782-794. https://doi.org/10.1161/01.RES.0000259593.07661.1e
  31. Lennon PF, Taylor CT, Stahl GL and Colgan SP. 1998. Neutrophil-derived 5'-adenosine promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188:1433-1443. https://doi.org/10.1084/jem.188.8.1433
  32. Lexer G, Cooper DK, Rose AG, Wicomb WN, Rees J, Keraan M and Du Toit E. 1986. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J. Heart Transplant. 5:411-418.
  33. Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JG, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS and Platt JL. 1998. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101:1745-1756. https://doi.org/10.1172/JCI2134
  34. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K and Takashima A. 2002. CD39 is the dominant Langerhans cell associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8:358-365. https://doi.org/10.1038/nm0402-358
  35. Ohtsuka T, Changelian PS, Bouis D, Noon K, Harada H, Lama VN and Pinsky DJ. 2010. Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. J. Immunol. 185:1321-1329. https://doi.org/10.4049/jimmunol.0901847
  36. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y and Ayares DL. 2003. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299:411-414. https://doi.org/10.1126/science.1078942
  37. Saze Z, Schuler PJ, Hong C-S, Cheng D, Jackson EK and Whiteside TL. 2013. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 122:9-18. https://doi.org/10.1182/blood-2013-02-482406
  38. Siegel JB, Grey ST, Lesnikoski BA, Kopp CW, Soares M, Schulte am Esch J, Bach FH and Robson SC. 1997. Xenogeneic endothelial cells activate human prothrombin. Transplantation 64:888-896. https://doi.org/10.1097/00007890-199709270-00017
  39. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC and Colgan SP. 2004. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200:1395-1405. https://doi.org/10.1084/jem.20040915
  40. Tseng YL, Kuwaki K, Dor FJ, Shimizu A, Houser S, Hisaghi Y, Yamada K, Robson SC, Awwad M, Schuurman HJ, Sachs DH and Cooper DK. 2005. alpha-1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80:1493-1500. https://doi.org/10.1097/01.tp.0000181397.41143.fa
  41. van Denderen BJ, Salvaris E, Romanella M, Aminian A, Katerelos M, Tange MJ, Pearse MJ and d'Apice AJ. 1997. Combination of decay-accelerating factor expression and alpha-1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury. Transplantation 64:882-888. https://doi.org/10.1097/00007890-199709270-00016
  42. Yegutkin GG, Wieringa B, Robson SC and Jalkanen S. 2012. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. FASEB J. 26:3875-3883. https://doi.org/10.1096/fj.12-205658
  43. Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamian P and Mignatti P. 2000. Expresstion of von willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int. J. Cancer 85:281-288. https://doi.org/10.1002/(SICI)1097-0215(20000115)85:2%3C281::AID-IJC21%3E3.0.CO;2-3
  44. 오건봉, 이해선, 황성수, 옥선아, 정학재, 변승준, 이풍연, 임기순. 2016. 돼지 혈관내피세포 특이적 CD73 발현 벡터가 도입된 돼지섬유아세포 생산. 한국수정란이식학회지 31:161-168.
  45. 이건섭, 박상현, 이해선, 지수정, 이주영, 변승준, 황성수, 김경운, 옥선아, 오건봉. 2017. 이종이식에 활용할 .1,3-galactosyltransferase 비활성화 및 Membrane Cofactor Protein 발현 동형접합 형질전환 돼지 개발. 한국수정란이식학회지 32:73-79.